BG107361A - Елетриптанов състав под формата на частици със сигмоидален модел на контролирано освобождаване - Google Patents

Елетриптанов състав под формата на частици със сигмоидален модел на контролирано освобождаване Download PDF

Info

Publication number
BG107361A
BG107361A BG107361A BG10736102A BG107361A BG 107361 A BG107361 A BG 107361A BG 107361 A BG107361 A BG 107361A BG 10736102 A BG10736102 A BG 10736102A BG 107361 A BG107361 A BG 107361A
Authority
BG
Bulgaria
Prior art keywords
eletriptan
composition according
pharmaceutically acceptable
drug
release
Prior art date
Application number
BG107361A
Other languages
Bulgarian (bg)
English (en)
Inventor
RASPIDE Manaud DE
Ross MACRAE
Mathias Walther
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of BG107361A publication Critical patent/BG107361A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)
BG107361A 2000-08-02 2002-12-06 Елетриптанов състав под формата на частици със сигмоидален модел на контролирано освобождаване BG107361A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0018968.8A GB0018968D0 (en) 2000-08-02 2000-08-02 Particulate composition
PCT/IB2001/001279 WO2002009675A1 (en) 2000-08-02 2001-07-18 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release

Publications (1)

Publication Number Publication Date
BG107361A true BG107361A (bg) 2003-06-30

Family

ID=9896843

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107361A BG107361A (bg) 2000-08-02 2002-12-06 Елетриптанов състав под формата на частици със сигмоидален модел на контролирано освобождаване

Country Status (38)

Country Link
US (1) US20020034545A1 (cs)
EP (1) EP1365748B1 (cs)
JP (1) JP2004505034A (cs)
KR (1) KR20030024820A (cs)
CN (1) CN1630511A (cs)
AP (1) AP2001002233A0 (cs)
AR (1) AR030099A1 (cs)
AT (1) ATE308978T1 (cs)
AU (1) AU2001270932A1 (cs)
BG (1) BG107361A (cs)
BR (1) BR0112839A (cs)
CA (1) CA2417887C (cs)
CZ (1) CZ2003241A3 (cs)
DE (1) DE60114887T2 (cs)
EA (1) EA200300110A1 (cs)
EC (1) ECSP034451A (cs)
EE (1) EE200300051A (cs)
ES (1) ES2250429T3 (cs)
GB (1) GB0018968D0 (cs)
GT (1) GT200100149A (cs)
HR (1) HRP20030036A2 (cs)
HU (1) HUP0301453A2 (cs)
IL (1) IL153494A0 (cs)
IS (1) IS6649A (cs)
MA (1) MA26934A1 (cs)
MX (1) MXPA03000999A (cs)
NO (1) NO20030498L (cs)
NZ (1) NZ522976A (cs)
OA (1) OA12348A (cs)
PA (1) PA8523101A1 (cs)
PE (1) PE20020385A1 (cs)
PL (1) PL359847A1 (cs)
SK (1) SK1082003A3 (cs)
SV (1) SV2002000574A (cs)
TN (1) TNSN01115A1 (cs)
UY (1) UY26861A1 (cs)
WO (1) WO2002009675A1 (cs)
ZA (1) ZA200300868B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
WO2004054518A1 (en) * 2002-12-16 2004-07-01 Chx Technologies, Inc. Temporary, pharmacologically-inactive dental coating for the in situ protection of dental therapeutic agents from saliva and abrasion from chewing
MXPA05010070A (es) 2003-04-11 2005-11-23 Pfizer Combinacion farmaceutica.
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
WO2005120456A2 (en) * 2004-06-09 2005-12-22 Pfizer Limited Formulation of eletriptan
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
JPWO2006080481A1 (ja) * 2005-01-31 2008-06-19 杏林製薬株式会社 マルチプルユニット型経口徐放性製剤及びその製造方法
US11311490B2 (en) 2005-08-10 2022-04-26 Add Advanced Drug Delivery Technologies Ltd. Oral preparation with controlled release
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
ATE496623T1 (de) * 2006-04-26 2011-02-15 Supernus Pharmaceuticals Inc Oxcarbazepin-zubereitungen für kontrollierte freisetzung mit sigmoidalem freisetzungsprofil
WO2008115797A1 (en) * 2007-03-16 2008-09-25 Pavo, Inc. Therapeutic compositions and methods
WO2009015336A2 (en) 2007-07-25 2009-01-29 Biolex Therapeutics, Inc. Controlled release interferon drug products and treatment of hcv infection using same
US9284416B2 (en) 2009-11-16 2016-03-15 Evonik Roehm Gmbh Process for converting a solid (meth)acrylate copolymer into a dispersed form by means of a dispersing agent
EP3191093A4 (en) * 2014-09-09 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
GB201716716D0 (en) * 2017-10-12 2017-11-29 Univ Of Hertfordshire Higher Education Corporation Method for coating particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release

Also Published As

Publication number Publication date
HRP20030036A2 (en) 2003-04-30
DE60114887T2 (de) 2006-07-20
NO20030498D0 (no) 2003-01-31
AP2001002233A0 (en) 2001-09-30
UY26861A1 (es) 2002-02-28
IS6649A (is) 2002-12-05
TNSN01115A1 (fr) 2005-11-10
EE200300051A (et) 2004-10-15
MXPA03000999A (es) 2003-06-09
MA26934A1 (fr) 2004-12-20
OA12348A (en) 2004-03-19
KR20030024820A (ko) 2003-03-26
PL359847A1 (en) 2004-09-06
CN1630511A (zh) 2005-06-22
EP1365748B1 (en) 2005-11-09
NZ522976A (en) 2004-11-26
SK1082003A3 (en) 2004-09-08
AU2001270932A1 (en) 2002-02-13
US20020034545A1 (en) 2002-03-21
PA8523101A1 (es) 2002-08-26
PE20020385A1 (es) 2002-05-11
ES2250429T3 (es) 2006-04-16
ECSP034451A (es) 2003-03-10
CA2417887A1 (en) 2002-02-07
JP2004505034A (ja) 2004-02-19
IL153494A0 (en) 2003-07-06
GB0018968D0 (en) 2000-09-20
SV2002000574A (es) 2002-12-02
WO2002009675A1 (en) 2002-02-07
CA2417887C (en) 2006-11-14
DE60114887D1 (de) 2005-12-15
EP1365748A2 (en) 2003-12-03
CZ2003241A3 (cs) 2004-02-18
AR030099A1 (es) 2003-08-13
WO2002009675A9 (en) 2003-07-10
HUP0301453A2 (hu) 2003-08-28
BR0112839A (pt) 2003-06-24
NO20030498L (no) 2003-01-31
EA200300110A1 (ru) 2003-06-26
GT200100149A (es) 2002-06-25
ZA200300868B (en) 2004-04-16
ATE308978T1 (de) 2005-11-15

Similar Documents

Publication Publication Date Title
RU2095054C1 (ru) Твердая лекарственная форма для орального введения
JP3403203B2 (ja) ダリフェナシン含有製剤
CA2618212C (fr) Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte et son application therapeutique
EP1562573B1 (en) Pharmaceutical pellets comprising tamsulosin and a process for making the same
US6117453A (en) Solid compositions containing polyethylene oxide and an active ingredient
JP2002523443A (ja) オメプラゾール製剤
JP2008303223A (ja) 脈動用量薬剤経口送達システム
JP2002532425A (ja) 新規な医薬製剤
BG107361A (bg) Елетриптанов състав под формата на частици със сигмоидален модел на контролирано освобождаване
EP1964553A1 (en) Sustained release pharmaceutical composition of tolterodine
US20110244033A1 (en) Tamsulosin pellets for fixed dose combination
PL192648B1 (pl) Preparat farmaceutyczny o kontrolowanym uwalnianiu, zawierający inhibitor ACE jako substancję aktywną
JP2001500150A (ja) ［Ｒ―（Ｚ）］―α―（メトキシイミノ）―α―（１―アザビシクロ［２．２．２］オクト―３―イル）アセトニトリル一塩酸塩の制御放出投与形態
US20090220593A1 (en) Extended release dosage forms of quetiapine
RU2275191C2 (ru) Состоящие из множества частиц фармацевтические составы с контролируемым высвобождением избирательного ингибитора повторного поглощения серотонина
WO2009065130A2 (en) Modified release formulations of diltiazem
JP2000502066A (ja) 徐放性シサプリド
US8778395B2 (en) Diltiazem controlled release formulation and method of manufacture
JP4837895B2 (ja) 放出制御組成物